Recombinant multi-species PDE6G/H/PDE6H protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PDE6G/H/PDE6H protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the inhibitory (or gamma) subunit of the cone-specific cGMP phosphodiesterase, which is a tetramer composed of two catalytic chains (alpha and beta), and two inhibitory chains (gamma). It is specifically expressed in the retina, and is involved in the transmission and amplification of the visual signal. Mutations in this gene are associated with retinal cone dystrophy type 3A (RCD3A). [provided by RefSeq, Mar 2010]
The Alternative Names of target: 5'-cyclic phosphodiesterase subunit gamma,A930033D18Rik,ACHM6,GMP-PDE gamma,H,PDE6G,PDE6H,PDEgamma,Pde6g,Pde6h,RCD3,Retinal cone rhodopsin-sensitive cGMP 3'
Go
to PDE6G/H/PDE6H products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP9444-Ag-1/ GM-Tg-hg-IP9444-Ag-2 | Human PDE6G/H/PDE6H protein | Human |
| GM-Tg-rg-IP9444-Ag-1/ GM-Tg-rg-IP9444-Ag-2 | Rat PDE6G/H/PDE6H protein | Rat |
| GM-Tg-mg-IP9444-Ag-1/ GM-Tg-mg-IP9444-Ag-2 | Mouse PDE6G/H/PDE6H protein | Mouse |
| GM-Tg-cynog-IP9444-Ag-1/ GM-Tg-cynog-IP9444-Ag-2 | Cynomolgus/Rhesus macaque PDE6G/H/PDE6H protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP9444-Ag-1/ GM-Tg-felg-IP9444-Ag-2 | Feline PDE6G/H/PDE6H protein | Feline |
| GM-Tg-cang-IP9444-Ag-1/ GM-Tg-cang-IP9444-Ag-2 | Canine PDE6G/H/PDE6H protein | Canine |
| GM-Tg-bovg-IP9444-Ag-1/ GM-Tg-bovg-IP9444-Ag-2 | Bovine PDE6G/H/PDE6H protein | Bovine |
| GM-Tg-equg-IP9444-Ag-1/ GM-Tg-equg-IP9444-Ag-2 | Equine PDE6G/H/PDE6H protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP9444-Ag-1/ GM-Tg-hg-IP9444-Ag-2;
GM-Tg-rg-IP9444-Ag-1/ GM-Tg-rg-IP9444-Ag-2;
GM-Tg-mg-IP9444-Ag-1/ GM-Tg-mg-IP9444-Ag-2; GM-Tg-cynog-IP9444-Ag-1/ GM-Tg-cynog-IP9444-Ag-2; GM-Tg-felg-IP9444-Ag-1/ GM-Tg-felg-IP9444-Ag-2; GM-Tg-cang-IP9444-Ag-1/ GM-Tg-cang-IP9444-Ag-2; GM-Tg-bovg-IP9444-Ag-1/ GM-Tg-bovg-IP9444-Ag-2; GM-Tg-equg-IP9444-Ag-1/ GM-Tg-equg-IP9444-Ag-2 |
| Products Name | PDE6G/H/PDE6H protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PDE6G/H/PDE6H |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PDE6G/H/PDE6H protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.